...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Alpine Immune buyout by Vertex

"ITs absolutely unreal why DM won't step aside and bring in a seasoned Biotech executive  to get a deal done."  

Last years AGM gave us their direction-

They are working with Cencora to develop their market

Odd that Cencora was not mentioned in the 3rd Qtr MD&A

The incompetence is mindboggling

 

Share
New Message
Please login to post a reply